Engrail Therapeutics

Engrail Therapeutics is a developer of drugs for neurological disorders, aiming to transform the lives of patients suffering from such conditions. Engrail Therapeutics combines biological insights with clinically meaningful solutions to build and advance a diverse portfolio of translational medicine products. Engrail Therapeutics utilizes a flexible transaction model to advance assets through proven mechanisms and effectively transition them from development to commercialization. The dedicated team at Engrail Therapeutics spares no effort to ensure that therapies ultimately benefit patients with life-limiting conditions.